On February 27^th, 2015, the national newspaper Corriere della Sera  has published on its section “Corriere Sociale,” dedicated to volunteering and Third Sector, an article on CVBF and its activities in the field of rare diseases and paediatrics.

The page describes the four main focus areas of the Consortium: Clinical Trials  (promotion of an ethical use of medication, ethics and regulatory counselling, organisation and conduction of clinical trials, pharmacovigilance services, CRO and CME providers activities and drug management), Regulatory Consultancy  (whose value lies in the set of competencies guaranteed by the consortium members), Scientific Research  (in particular paediatric clinical research, conducted in the context of European projects), Training  (with particular regard to the DEEP project and its significant contribution in the field of paediatric research, with the aim of making the iron chelating agent deferiprone– DFP, available in a new formulation specifically tested for children with β-thalassaemia and other transfusion dependent haemoglobinopathies).

Here you can download the complete article.